Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia

International Journal of Antimicrobial Agents

Volumn 30, Issue 2, 2007, Pages 129-133

  Hsueh, Po Ren ^a   Hawkey, Peter Michael ^b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

Antimicrobial therapy; Asia; Consensus; Intra abdominal infections

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CARBAPENEM; CEFEPIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERTAPENEM; FLOMOXEF; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MONOBACTAM; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; BACTERIUM ISOLATE; CONSENSUS; DISEASE SEVERITY; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG USE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ABDOMEN; ANTI-INFECTIVE AGENTS; ASIA; BACTERIAL INFECTIONS; BETA-LACTAMASES; CONSENSUS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FLUOROQUINOLONES; HUMANS; PENICILLANIC ACID; PIPERACILLIN; PRACTICE GUIDELINES;

EID: 34347263013     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.03.002     Document Type: Article

References (7)

1. Hsueh P.R., Snyder T.A., Dinubile M.J., et al., 2004 Asia-Pacific SMART Team. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents 28 (2006) 238-243
2. Lin W.J., Lo W.T., Chu C.C., Chu M.L., and Wang C.C. Bacteriology and antibiotic susceptibility of community-acquired intra-abdominal infections in children. J Microbiol Immunol Infect 39 (2006) 249-254
3. Teng L.J., Hsueh P.R., Tsai J.C., Liaw S.J., Ho S.W., and Luh K.T. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob Agents Chemother 46 (2002) 2908-2913
4. Lee K., Chong Y., Jeong S.H., Xu X.S., and Kwon O.H. Emerging resistance of anaerobic bacteria to antimicrobial agents in South Korea. Clin Infect Dis 23 Suppl. 1 (1996) S73-S77
5. Shinagawa N., Taniguchi M., Hirata K., et al. Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents-special references to bacteria isolated between April 2003 and March 2004. Jpn J Antibiot 59 (2006) 72-116 [in Japanese]
6. Solomkin J.S., Mazuski J.E., Baron E.J., et al. Infectious Diseases Society of America Guidelines for the selection of anti-infective agents for complicated intra-abdominal infections. Clin Infect Dis 37 (2003) 997-1005
7. Mazuski J.E., Sawyer R.G., Nathens A.B., et al. Therapeutic Agents Committee of the Surgical Infections Society. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: an executive summary. Surg Infect (Larchmt) 3 (2002) 161-173